Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page's metadata without affecting the study information presented.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study's update history now includes new dates: 2026-08-13, 2026-08-12, and 2026-08. Older dates 2026-07-31, 2026-07-30, and 2026-02 have been removed.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a deployment of an updated page version.SummaryDifference0.0%

- Check31 days agoChange DetectedUPMC Hillman Cancer Center was added as a participating location and University of Pittsburgh Cancer Institute (UPCI) was removed from the list of participating sites.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays a new site revision label: Revision: v3.6.4, replacing the previous version tag. This indicates a minor site update without impacting study data or navigation.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new release/build of the study details page.SummaryDifference0.0%

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.